Inappropriate proton pump inhibitor lansoprazole prescription in older adults hospitalized in long-term care unit

[1] Targownik LE(2022)AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review Gastroenterology 162 1334-1342

[2] Fisher DA(2019)Proton pump inhibitors in the elderly, balancing risk and benefit: an age-old problem Curr Gastroenterol Rep 21 65-16

[3] Saini SD(2020)Critical assessment of long-term proton pump inhibitor use in the elderly Rev Med Liege 75 10-143

[4] Kanno T(2021)Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors Aliment Pharmacol Ther 54 129-784

[5] Moayyedi P(2006)Pharmacokinetic drug interaction profiles of proton pump inhibitors Drug Saf 29 769-557

[6] Delhougne N(2021)Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention Medicine (Baltimore) 100 551-715

[7] Allepaerts S(2001)Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein Naunyn Schmiedebergs Arch Pharmacol 364 706-4

[8] Gast P(2017)The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association Gastroenterology 152 673.e1-72

[9] Louis E(2016)Effect of a proton pump inhibitor deprescribing guideline on drug usage and costs in long-term care J Am Med Dir Assoc 17 65-24

[10] Salvo EM(2018)We have had a gutful: the need for deprescribing proton pump inhibitors J Clin Pharm Ther 43 19-1400

[1] Targownik LE(2022)AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review Gastroenterology 162 1334-1342

[2] Fisher DA(2019)Proton pump inhibitors in the elderly, balancing risk and benefit: an age-old problem Curr Gastroenterol Rep 21 65-16

[3] Saini SD(2020)Critical assessment of long-term proton pump inhibitor use in the elderly Rev Med Liege 75 10-143

[4] Kanno T(2021)Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors Aliment Pharmacol Ther 54 129-784

[5] Moayyedi P(2006)Pharmacokinetic drug interaction profiles of proton pump inhibitors Drug Saf 29 769-557

[6] Delhougne N(2021)Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention Medicine (Baltimore) 100 551-715

[7] Allepaerts S(2001)Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein Naunyn Schmiedebergs Arch Pharmacol 364 706-4

[8] Gast P(2017)The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association Gastroenterology 152 673.e1-72

[9] Louis E(2016)Effect of a proton pump inhibitor deprescribing guideline on drug usage and costs in long-term care J Am Med Dir Assoc 17 65-24

[10] Salvo EM(2018)We have had a gutful: the need for deprescribing proton pump inhibitors J Clin Pharm Ther 43 19-1400